Member access

4-Traders Homepage  >  Shares  >  Tokyo  >  Terumo Corp    4543   JP3546800008


News SummaryMost relevantAll newsSector news 

Terumo : Expands Production in Asia New Factory Established and Existing Facilities Expanded in Vietnam and the Philippines

05/10/2012 | 03:13am US/Eastern
May 10, 2012

Terumo Corporation (TOKYO:4543) announced today that it will expand its production facilities in Asia to meet anticipated sales increases in the medium to long term, based on its corporate growth strategy. Terumo Corporation will establish a new factory in Vietnam, its second in the country, as well as expand the production scale of existing factories in Vietnam and the Philippines. The total amount invested will be 15 billion yen.

The new factory in Vietnam will produce blood management products such as blood bags to meet growing global demand, especially in emerging countries.
In cooperation with Ashitaka factory (Shizuoka prefecture) and the new Yamaguchi factory in Japan (operation to be started in 2015), the existing factory in Vietnam will expand the production scale of interventional systems products, sales of which have been growing at a double-digit pace. The company will also establish a new production building at the existing factory in the Philippines to cope with needed production increases of syringes and needles.
To improve its global competitiveness, Terumo Corporation is seeking to enhance the production capacity across all of its three business areas: Cardiac & Vascular, General Hospital, and Blood Management.

Terumo Corporation's global production system

Terumo Corporation is accelerating its growth globally, and plans to increase the percent of production done outside Japan in line with the growth in the share of net sales outside Japan, which already account for over half of the total. Accordingly, the company has positioned factories in Asia as its global production center and is already producing a broad range of products in China, the Philippines, and Vietnam.
On another front, certain highly advanced and precise production technologies are difficult to transfer outside of Japan. The company has designated factories in Japan as mother production factories that develop and refine core manufacturing technologies to underpin product improvement.
Terumo Corporation will continue to enhance its global production system in factories in Asia and Japan to meet growing global demand while increasing cost competitiveness.

Factories Overview 1. Vietnam: a new factory to be established

In April 2012, Terumo BCT was established through the integration of CaridianBCT and Terumo Transfusion, following Terumo Corporation's acquisition of CaridianBCT in April 2011. The company will establish a new factory in Vietnam to produce blood management products to meet growing global demand, especially in emerging countries. The factory will be its sixth production facilities of blood management products, following ones in Japan, U.S., UK

React to this article
Latest news on TERUMO CORP
07:07a TERUMO : FAMHP advises patients to not suspend nor stop any treatments
03/27 TERUMO CORP : ex-dividend day for final dividend
03/25 TERUMO : Europe responds to broadcast EenVandaag Injection needles pose no healt..
02/25 TERUMO : Metactive Appoints David Ferrera to the Board of Directors
02/17 TERUMO : Establishes a New RD Center for Interventional Business in Southern Cal..
02/13 TERUMO : Biosensors Reports Financial Results for the Third Quarter of Fiscal Ye..
01/30 TERUMO : Cardiovascular Group Announces Expansion Of Its Elkton, Maryland Manufa..
2014 TERUMO : MicroVention Assigned Patent
2014 TERUMO : Biosensors Reports Financial Results for the Second Quarter and First H..
2014 BSD MEDICAL : Posts Findings from MicroThermX Microwave Ablation System Study
Duration : Period :
Terumo Corp Technical Analysis Chart | 4543 | JP3546800008 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes